These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35257253)

  • 1. ASO Author Reflections: When is the Best Time to Perform Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for a Recurrent Low-Grade Appendiceal Mucinous Neoplasm?
    Valenzuela CD; Votanopoulos KI; Levine EA; Shen P
    Ann Surg Oncol; 2022 Jun; 29(6):3432-3433. PubMed ID: 35257253
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Evaluating Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Mangieri CW; Levine EA
    Ann Surg Oncol; 2022 Jan; 29(1):212-213. PubMed ID: 34467501
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Disparate Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Based on Insurance Status.
    Hanna DN; Magge D
    Ann Surg Oncol; 2022 Jan; 29(1):260-261. PubMed ID: 34455512
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Significance of Primary Tumor Location and Genomic Alterations in Colorectal Peritoneal Metastases and Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy.
    Hamed AB; Choudry MH
    Ann Surg Oncol; 2023 Jul; 30(7):4471-4472. PubMed ID: 37103724
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Neoadjuvant Chemotherapy for High-Grade Appendiceal Neoplasms Before Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Closer to Evidence-Based Practice?
    Mangieri CW; Levine EA
    Ann Surg Oncol; 2022 Apr; 29(4):2649-2650. PubMed ID: 35001235
    [No Abstract]   [Full Text] [Related]  

  • 6. Single-Port Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Alshammari T; Alshammari S; Hakami R; Alharbi A; Alyami M; Abdulla M; Bin Traiki T
    Am J Case Rep; 2019 Nov; 20():1648-1651. PubMed ID: 31704906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASO Author Reflections: Thirty Years of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Wake Forest University.
    Valenzuela CD; Levine EA; Votanopoulos KI; Shen P
    Ann Surg Oncol; 2022 Jun; 29(6):3446-3447. PubMed ID: 35275327
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: If at First You Don't Succeed, Try, Try Again: Iterative CRS/HIPEC for Recurrent Mucinous Appendix Cancer.
    Lopez-Ramirez F; King MC; Gushchin V; Sardi A
    Ann Surg Oncol; 2022 Jun; 29(6):3402-3403. PubMed ID: 35015184
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Tonello M; Sommariva A
    Ann Surg Oncol; 2022 Jun; 29(6):3418-3419. PubMed ID: 34743279
    [No Abstract]   [Full Text] [Related]  

  • 10. Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Mehta A; Mittal R; Chandrakumaran K; Carr N; Dayal S; Mohamed F; Moran B; Cecil T
    Dis Colon Rectum; 2017 Nov; 60(11):1155-1161. PubMed ID: 28991079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASO Author Reflections: Augmenting Clinical Decision-Making Around Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Through Traditional and Machine Learning Algorithms.
    Greenberg AL; Bartlett DL; Choudry HM; Adam MA
    Ann Surg Oncol; 2023 Sep; 30(9):5443-5444. PubMed ID: 37266807
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis.
    Martins M; Santos-Sousa H; Araújo F; Nogueiro J; Sousa-Pinto B
    Ann Surg Oncol; 2022 Nov; 29(12):7538-7539. PubMed ID: 35907988
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Organ-Specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy-A Scoping Review.
    Balachandran R
    Ann Surg Oncol; 2022 Sep; 29(9):6084-6085. PubMed ID: 35190947
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Quality-of-Life Trajectories After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Steffens D; Moran B
    Ann Surg Oncol; 2020 Oct; 27(10):3995-3996. PubMed ID: 32297085
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Changes in Coagulation Biomarkers and the Risk for Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Dranichnikov P
    Ann Surg Oncol; 2021 Nov; 28(12):7783. PubMed ID: 33988793
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: The Timing of Onset of Peritoneal Metastases from Colorectal Carcinoma Is Not an Independent Predictor of Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Dietz MV; Madsen EVE
    Ann Surg Oncol; 2022 Oct; 29(11):6577-6578. PubMed ID: 35486267
    [No Abstract]   [Full Text] [Related]  

  • 17. CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
    Kozman MA; Fisher OM; Rebolledo BJ; Valle SJ; Alzahrani N; Liauw W; Morris DL
    Eur J Surg Oncol; 2017 Dec; 43(12):2299-2307. PubMed ID: 28993033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASO Author Reflections: Routine Omentectomy During Cytoreductive Surgery and HIPEC.
    Khan S; Baumgartner JM
    Ann Surg Oncol; 2023 Feb; 30(2):774-775. PubMed ID: 36367628
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases.
    Laks S; Adileh M; Ben-Yaacov A; Nissan A
    Ann Surg Oncol; 2021 Sep; 28(9):5339-5340. PubMed ID: 33604829
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis.
    Pallas N; Karamveri C; Kyziridis D; Hristakis C; Kyriakopoulos V; Kalakonas A; Vaikos D; Tentes AK
    J BUON; 2017; 22(6):1547-1553. PubMed ID: 29332351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.